Recent Finacing
Recent Raise
Cytos develops CYT003-QbG10, an allergen-independent immunotherapy for allergic asthma built on its Immunodrug platform, advancing pipeline programs toward a global Phase IIb trial.
Focus Areas
Total Raised
Funding round
